Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Mov Disord. 2016 Jul 30;31(12):1846–1853. doi: 10.1002/mds.26732

Figure 4.

Figure 4

FDI-MEP from the simultaneous LFP-TMS phase; individual subjects. A) All but one subject show FDI-MEP suppression for successful stop trials vs. go trials. B) All but two subjects show greater FDI-MEP suppression for successful stop-trials with greater beta-power.